1. Suriano G, Azevedo L, Novais M, Boscolo B, Seruca R, Amorim A, Ghibaudi EM

In vitro demonstration of intra-locus compensation using the ornithine transcarbamylase protein as model. Human molecular genetics 16: 2209-14, 2007. [Article] 

 doi: 10.1093/hmg/ddm172 PMID: 17613537.

 

2. Suriano G, Seixas S, Rocha J, Seruca R

A model to infer the pathogenic significance of CDH1 germline missense variants. Journal of molecular medicine (Berlin, Germany) 84: 1023-31, 2006. [Article] 

 doi: 10.1007/s00109-006-0091-z PMID: 16924464.

 

3. Suriano G, Ferreira P, Mateus AR, Correia J, Henriques L, Seruca R

Genetics of hereditary diffuse gastric cancer: progress and future challenges. Future oncology (London, England) 2: 363-70, 2006. [] 

 doi: 10.2217/14796694.2.3.363 PMID: 16787116.

 

4. Suriano G, Yew S, Ferreira P, Senz J, Kaurah P, Ford JM, Longacre TA, Norton JA, Chun N, Young S, Oliveira MJ, Macgillivray B, Rao A, Sears D, Jackson CE, Boyd J, Yee C, Deters C, Pai GS, Hammond LS, McGivern BJ, Medgyesy D, Sartz D, Arun B, Oelschlager BK, Upton MP, Neufeld-Kaiser W, Silva OE, Donenberg TR, Kooby DA, Sharma S, Jonsson BA, Gronberg H, Gallinger S, Seruca R, Lynch H, Huntsman DG

Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clinical cancer research : an official journal of the American Association for Cancer Research 11: 5401-9, 2005. [Article] 

 doi: 10.1158/1078-0432.CCR-05-0247 PMID: 16061854.

 

5. Suriano G, Vrcelj N, Senz J, Ferreira P, Masoudi H, Cox K, Nabais S, Lopes C, Machado JC, Seruca R, Carneiro F, Huntsman DG

beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer. Genes, chromosomes & cancer 42: 238-46, 2005. [Article] 

 doi: 10.1002/gcc.20135 PMID: 15609344.

 

6. Suriano G, Oliveira C, Ferreira P, Machado JC, Bordin MC, De Wever O, Bruyneel EA, Moguilevsky N, Grehan N, Porter TR, Richards FM, Hruban RH, Roviello F, Huntsman D, Mareel M, Carneiro F, Caldas C, Seruca R

Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Human molecular genetics 12: 575-82, 2003. [Article] 

 PMID: 12588804.

 

7. Suriano G, Oliveira MJ, Huntsman D, Mateus AR, Ferreira P, Casares F, Oliveira C, Carneiro F, Machado JC, Mareel M, Seruca R

E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Human molecular genetics 12: 3007-16, 2003. [Article] 

 doi: 10.1093/hmg/ddg316 PMID: 14500541.

 

8. Suriano G, Mulholland D, de Wever O, Ferreira P, Mateus AR, Bruyneel E, Nelson CC, Mareel MM, Yokota J, Huntsman D, Seruca R

The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene 22: 5716-9, 2003. [Article] 

 doi: 10.1038/sj.onc.1206672 PMID: 12944922.

 

9. Suriano G, Watanabe S, Ghibaudi EM, Bollen A, Ferrari RP, Moguilevsky N

Glu375Gln and Asp225Val mutants: about the nature of the covalent linkages between heme group and apo-Protein in bovine lactoperoxidase. Bioorganic & medicinal chemistry letters 11: 2827-31, 2001. [Article] 

 PMID: 11597409.

 

1. Simões-Correia J, Figueiredo J, Oliveira C, van Hengel J, Seruca R, van Roy F, Suriano G

Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. Human molecular genetics 17: 3566-76, 2008. [Article] 

 doi: 10.1093/hmg/ddn249 PMID: 18772194.

 

2. Moutinho C, Mateus AR, Milanezi F, Carneiro F, Seruca R, Suriano G

Epidermal growth factor receptor structural alterations in gastric cancer. BMC cancer 8: 10, 2008. [Article] 

 doi: 10.1186/1471-2407-8-10 PMID: 18199332.

 

3. Corso G, Roviello F, Paredes J, Pedrazzani C, Novais M, Correia J, Marrelli D, Cirnes L, Seruca R, Oliveira C, Suriano G

Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 33: 1061-7, 2007. [Article] 

 doi: 10.1016/j.ejso.2007.03.001 PMID: 17434710.

 

4. Ferreira P, Oliveira MJ, Beraldi E, Mateus AR, Nakajima T, Gleave M, Yokota J, Carneiro F, Huntsman D, Seruca R, Suriano G

Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Experimental cell research 310: 99-104, 2005. [Article] 

 doi: 10.1016/j.yexcr.2005.07.010 PMID: 16112667.